is focusing on mainly nanotechnology
startup companies with existing products, not blue sky research. The current venture capital business models are not
appropriate for investing in Nanotechnology. We are proposing a new
business model which combines the best of both worlds of venture capital
and angel investing which is a more hands-on approach to managing
companies to success. Seraphima is a play on the
word "seraphim", an angel, for the investment approach of this fund. This
does not mean we are limited to funding with angel money.
Nanotechnologies have potential to add significant value in performance
and eventually lower cost to many products across all sectors. These
commercial benefits are happening much sooner than most people think.
Nanotechnology is here and now.
Why Seraphima Ventures?
is expert in assessment, development and commercialization of nanotechnology
for investment. The Seraphima
Ventures team actually understands what is Nanotechnology.
Each of our team
members are both deep tech and business savvy with understanding
of the big picture impact on global markets as well as an eye and attention
for detail for such things as implementation of business strategies and
addressing management and marketing issues. We
will work onsite alongside with the portfolio companies.
Each team member brings along a very important network of contacts that
will ensure each of our invested companies’ success.
The old VC business
models cannot work with the broad understanding necessary for the
diverse technologies, applications and markets of nanotechnology. This
is a challenging sector in which to invest because it is so vast and expertise
is limited. We can capitalize on our experience to a sector
of high velocity growth through our expertise. We have a team and
business model uniquely qualified to sort through the noise to nurture winning investments. There’s more expert management
oversight and business strategy consulting and advisement to our startup in their industries.
We offer more value for less.
This Web site is for informational
purposes only and does not constitute a complete description of our
investment services or performance. This Web site is in no way a
solicitation of offer to sell securities or investment advisory services
except, where applicable, in states where we are registered or where an
exemption or exclusion from such registration exists. Information
throughout this site, whether stock quotes, charts, articles, or any
other statement or statements regarding market or other financial
information, is obtained from sources which we and our suppliers believe
reliable, but we do not warrant or guarantee the timeliness or accuracy
of this information. Nothing in this Web site should be interpreted to
state or imply that past results are an indication of future
performance. Neither we nor our information providers shall be liable
for any errors or inaccuracies, regardless of cause, or the lack of
timeliness, or for any delay or interruption in the transmission thereof
to the user. THERE ARE NO WARRANTIES EXPRESSED OR IMPLIED, AS TO
ACCURACY, COMPLETENESS, OR RESULTS OBTAINED FROM ANY INFORMATION POSTED
ON THIS OR ANY "LINKED WEB SITE."
Safe Harbor Statement
under the Private Securities Litigation Reform Act of 1995: The
statements contained in this press release that are not purely
historical are forward-looking statements within the meaning of Section
21E of the Securities and Exchange Act of 1934, as amended, including
its future operational plans and objectives including integration of
other businesses, its future business prospects, its future financial
performance, its future cash position, and its future prospects for
returns. All forward-looking statements included in this document are
based upon information available to Seraphima Ventures LLC. as of the
date hereof, and Seraphima Ventures LLC. assumes no obligation to update
any such forward-looking statements. Forward-looking statements involve
risks and uncertainties, which could cause actual results to differ
materially from those projected. These and other risks relating to
Seraphima Ventures’ business include risks associated with a slow-down
in the economy, risks associated with the financial condition of the
company’s portfolio, risks associated with competition, risks associated
with increases in costs and operating expenses, risks in technology
development and commercialization, the risk of operating losses, risks
in product development, risks associated with international and domestic
legal environments and changes, and other risks. Reported results should
not be considered an indication of future performance. You should not
place undue reliance on these forward-looking statements, which speak
only as the date hereof. Seraphima Ventures disclaims any obligation to
publicly update or revise any such forward-looking statements to reflect
any change in our expectations or in events, conditions, or
circumstances on which any such statements may be based, or that may
affect the likelihood that actual results will differ from those set
forth in the forward-looking statements.
This website does not
constitute or contain an offer to sell or a solicitation of an offer to
buy any securities in the United States or elsewhere. The securities in
the Company are not being registered under the U.S. Securities Act of
1933, as amended (the "Securities Act") as it is a private offering and
need not do so under guidelines of such act